Cliff Asness’s BBNX Holdings & Trades

First Buy
Q2 2025
Duration Held
2 Quarters
Largest Add
Q2 2025
+55,433 Shares
Current Position
52,010 Shares
$1.03 M Value

Cliff Asness's BBNX Position Overview

Cliff Asness (via Aqr Capital Management LLC) currently holds 52,010 shares of Beta Bionics, Inc. (BBNX) worth $1.03 M, representing 0.00% of the portfolio. First purchased in 2025-Q2, this recently established position has been held for 2 quarters.

Based on recent 13F filings, Cliff Asness has initiated a new position in BBNX, representing a fresh investment thesis on this company. Largest reduction occurred in Q3 2025, reducing 3,423 shares.

Analysis based on 13F filings available since 2013 Q2

Cliff Asness's Beta Bionics (BBNX) Holding Value Over Time

Track share changes against reported price movement

Quarterly Beta Bionics (BBNX) Trades by Cliff Asness

Period Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q2 2025 +55,433 New Buy 55,433 $14.56
Q3 2025 -3,423 Reduce 6.18% 52,010 $19.87

Cliff Asness's Beta Bionics Investment FAQs

Cliff Asness first purchased Beta Bionics, Inc. (BBNX) in Q2 2025, acquiring 55,433 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness has held Beta Bionics, Inc. (BBNX) for 2 quarters since Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness's largest addition to Beta Bionics, Inc. (BBNX) was in Q2 2025, adding 55,433 shares worth $807,105. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 52,010 shares of Beta Bionics, Inc. (BBNX), valued at approximately $1.03 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

As of the Q3 2025 filing, Beta Bionics, Inc. (BBNX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness's peak holding in Beta Bionics, Inc. (BBNX) was 55,433 shares, as reported at the end of Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.